Research output per year
Research output per year
Fingerprint
Dive into the research topics where John Storey is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Short I⋯O Interactions in the Crystal Structures of Two 2-Iodo-Phenyl Methyl-Amides as Substrates for Radical Translocation Reactions
Ishaq, A., Storey, J. M. D. & Harrison, W. T. A., 12 May 2023, In: Chemistry. 5, 2, p. 1233–1242 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Molecular structure and the twist-bend nematic phase: the role of spacer length in liquid crystal dimers
Paterson, D. A., Walker, R., Storey, J. M. D. & Imrie, C. T., 13 Apr 2023, (E-pub ahead of print) In: Liquid Crystals.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Using lateral substitution to control conformational preference and phase behaviour of benzanilide-based liquid crystal dimers
Strachan, G. J., Majewska, M., Pociecha, D., Imrie, C. T. & Storey, J. M. D., 3 Apr 2023, In: ChemPhysChem. 24, 7, 9 p., e202200758.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
The effects of alkylthio chains on the properties of symmetric liquid crystal dimers
Cruickshank, E., Strachan, G. J., Majewska, M. M., Pociecha, D., Gorecka, E., Storey, J. M. D. & Imrie, C. T., 20 Mar 2023, In: New Journal of Chemistry. 47, 15, p. 7356-7368 13 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Intrinsically Chiral Twist-Bend Nematogens: Interplay of Molecular and Structural Chirality in the NTB Phase
Walker, R., Pociecha, D., Salamonczyk, M., Storey, J. M. D., Gorecka, E. & Imrie, C. T., 14 Mar 2023, In: ChemPhysChem. 24, 6, e202200807.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus)
Datasets
-
Crystal structures of four indole derivatives as possible cannabinoid allosteric antagonists: CCDC 1062393: Experimental Crystal Structure Determination
Kerr, J. R. (Contributor), Trembleau, L. (Contributor), Storey, J. (Contributor), Wardell, J. L. (Contributor) & Harrison, W. (Contributor), Cambridge Crystallographic Data Centre, 29 Apr 2015
DOI: 10.5517/cc14nhr1
Dataset
-
Crystal structures of four indole derivatives as possible cannabinoid allosteric antagonists: CCDC 1062392: Experimental Crystal Structure Determination
Kerr, J. R. (Contributor), Trembleau, L. (Contributor), Storey, J. (Contributor), Wardell, J. L. (Contributor) & Harrison, W. (Contributor), Cambridge Crystallographic Data Centre, 29 Apr 2015
DOI: 10.5517/cc14nhq0
Dataset
-
Crystal structures of four indole derivatives as possible cannabinoid allosteric antagonists: CCDC 1062391: Experimental Crystal Structure Determination
Kerr, J. R. (Contributor), Trembleau, L. (Contributor), Storey, J. (Contributor), Wardell, J. L. (Contributor) & Harrison, W. (Contributor), Cambridge Crystallographic Data Centre, 29 Apr 2015
DOI: 10.5517/cc14nhpz
Dataset
-
Crystal structures of four indole derivatives as possible cannabinoid allosteric antagonists: CCDC 1062390: Experimental Crystal Structure Determination
Kerr, J. R. (Contributor), Trembleau, L. (Contributor), Storey, J. (Contributor), Wardell, J. L. (Contributor) & Harrison, W. (Contributor), Cambridge Crystallographic Data Centre, 29 Apr 2015
DOI: 10.5517/cc14nhny
Dataset
Impacts
-
Development of treatments & diagnostics for Alzheimer’s disease
John Storey (Coordinator)
Impact: Other Impacts
-
Discovery and commercialisation of an entirely new drug for the treatment of Alzheimer's disease
Claude Wischik (Participant), Charles Harrington (Participant), John Storey (Participant), Janet Rickard (Participant), David Horsley (Participant), Thomas Baddeley (Participant), Steven Kemp (Participant), James Sinclair (Participant), Claudia Zabke (Participant), F. Theuring (Participant), F Stamer (Participant) & C Marshall (Participant)
Impact: Health and Wellbeing, Economic and/or Commercial
-
Discovery and development of a new drug for the treatment of dementia
Claude Wischik (Coordinator), Charles Harrington (Coordinator), John Storey (Participant), Janet Rickard (Participant) & David Horsley (Participant)
Impact: Economic and/or Commercial
-